{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T23:14:17Z","timestamp":1788650057851,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005743","name":"Universit\u00e0 Cattolica del Sacro Cuore","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005743","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>Autologous and allogeneic hematopoietic stem cell transplantation and CAR-T cell therapy are standard treatments for patients affected by hematologic malignancies at different stages of their clinical pathway. Several adverse events accompany these therapies during patients\u2019 hospital stay, including psycho-emotional distress and various functional and social impairments.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In this monocentric study on 498 patients, various clinical and social fragility indices, registered within clinical documentation during the hospital stay, specifically at admission (within 24\u00a0h of entry) and discharge (less than 24\u00a0h prior to leaving), were retrospectively assessed with the aim of describing their trends and evaluating for differences between type of cell therapy and underlying disease.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Functional independence mean score was lower in allogeneic patients at admission (<jats:italic>p<\/jats:italic>\u2009=\u20090.001) and at discharge (<jats:italic>p<\/jats:italic>\u2009=\u20090.001), while a higher risk of falling at discharge (<jats:italic>p<\/jats:italic>\u2009=\u20090.001), an increased risk of clinical deterioration at admission (<jats:italic>p<\/jats:italic>\u2009=\u20090.001) and at discharge (<jats:italic>p<\/jats:italic>\u2009=\u20090.011), and increased complexity of care at both time points (<jats:italic>p<\/jats:italic>\u2009=\u20090.001) were observed in patients undergoing CAR-T compared to patients undergoing allogeneic or autologous HSCT procedures. Acute lymphoid leukemia patients had significantly worse mean scores at both time points for functional independence, risk of falling, clinical deterioration, care complexity, level of pain (<jats:italic>p<\/jats:italic>\u2009=\u2009\u2009&lt;\u20090.001); while acute myeloid leukemia patients had higher risk of skin pressure injuries at discharge (<jats:italic>p<\/jats:italic>\u2009=\u20090.036).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Our findings may contribute to improving personalized assessment strategies in the field of cell therapy, including both CAR-T therapy and stem cell transplantation. They highlight the increased risk and complexity of care, particularly in patients receiving CAR-T therapy, while emphasizing the need for tailored management approaches across different cell therapy modalities.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s00520-025-09925-5","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T02:28:30Z","timestamp":1758853710000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Dependence and clinical fragility in hematopoietic stem cell transplant and CAR-T therapy: a retrospective study"],"prefix":"10.1007","volume":"33","author":[{"given":"Marco","family":"Cioce","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Raponi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Visintini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Pascucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Botti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Laurenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Nuzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Vetrugno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Nicolotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Iula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Sica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Cornacchione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Calza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah Jayne","family":"Liptrott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"key":"9925_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21176091","volume":"21","author":"P Auberger","year":"2020","unstructured":"Auberger P, Tamburini-Bonnefoy J, Puissant A (2020) Drug resistance in hematological malignancies. Int J Mol Sci 21:6091. https:\/\/doi.org\/10.3390\/ijms21176091","journal-title":"Int J Mol Sci"},{"key":"9925_CR2","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/ejh.13851","volume":"109","author":"DM Pasqui","year":"2022","unstructured":"Pasqui DM, Latorraca CDOC, Pacheco RL, Riera R (2022) CAR-T cell therapy for patients with hematological malignancies. A systematic review. Eur J Haematol 109:601\u2013618. https:\/\/doi.org\/10.1111\/ejh.13851","journal-title":"Eur J Haematol"},{"key":"9925_CR3","doi-asserted-by":"publisher","unstructured":"Wallhult E, Kenyon Quinn, B (2023) Early and acute complications and the principles of HSCT nursing care. In: Kenyon, M., Babic, A. (eds) The European Blood and Marrow Transplantation Textbook for Nurses. Springer, Cham. https:\/\/doi.org\/10.1007\/978-3-031-23394-4_10","DOI":"10.1007\/978-3-031-23394-4_10"},{"key":"9925_CR4","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3747\/co.26.5033","volume":"26","author":"A Bazinet","year":"2019","unstructured":"Bazinet A, Popradi G (2019) A general practitioner\u2019s guide to hematopoietic stem-cell transplantation. Curr Oncol 26:187\u2013191. https:\/\/doi.org\/10.3747\/co.26.5033","journal-title":"Curr Oncol"},{"key":"9925_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.663201","volume":"12","author":"L Miao","year":"2021","unstructured":"Miao L, Zhang Z, Ren Z, Li Y (2021) Reactions related to CAR-T cell therapy. Front Immunol 12:663201. https:\/\/doi.org\/10.3389\/fimmu.2021.663201","journal-title":"Front Immunol"},{"key":"9925_CR6","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1080\/14787210.2021.1855143","volume":"19","author":"O Bupha-Intr","year":"2021","unstructured":"Bupha-Intr O, Haeusler G, Chee L et al (2021) CAR-t cell therapy and infection: a review. Expert Rev Anti-infect Ther 19:749\u2013758. https:\/\/doi.org\/10.1080\/14787210.2021.1855143","journal-title":"Expert Rev Anti-infect Ther"},{"key":"9925_CR7","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.jaci.2020.07.025","volume":"146","author":"CW Freyer","year":"2020","unstructured":"Freyer CW, Porter DL (2020) Cytokine release syndrome and neurotoxicity following CAR T-cell therapy for hematologic malignancies. J Allergy Clin Immunol 146:940\u2013948. https:\/\/doi.org\/10.1016\/j.jaci.2020.07.025","journal-title":"J Allergy Clin Immunol"},{"key":"9925_CR8","doi-asserted-by":"publisher","DOI":"10.4084\/MJHID.2020.067","volume":"12","author":"M Cioce","year":"2020","unstructured":"Cioce M, Lohmeyer FM, Moroni R et al (2020) Impact of educational interventions on psychological distress during allogeneic hematopoietic stem cell transplantation: a randomised study. Mediterr J Hematol Infect Dis 12:e2020067. https:\/\/doi.org\/10.4084\/MJHID.2020.067","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"9925_CR9","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1080\/07347332.2023.2181722","volume":"41","author":"M Cioce","year":"2023","unstructured":"Cioce M, Borrelli I, Cappucciati L et al (2023) The impact of education on patients\u2019 psycho-emotional status during allogeneic hematopoietic stem cell transplantation: a multicenter prospective study by thes Gruppo Italiano Trapianto di Midollo Osseo. J Psychosoc Oncol 41:687\u2013703. https:\/\/doi.org\/10.1080\/07347332.2023.2181722","journal-title":"J Psychosoc Oncol"},{"key":"9925_CR10","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1188\/17.ONF.96-107","volume":"44","author":"M Baliousis","year":"2017","unstructured":"Baliousis M, Rennoldson M, Dawson DL et al (2017) Perceptions of hematopoietic stem cell transplantation and coping predict emotional distress during the acute phase after transplantation. Oncol Nurs Forum 44:96\u2013107. https:\/\/doi.org\/10.1188\/17.ONF.96-107","journal-title":"Oncol Nurs Forum"},{"key":"9925_CR11","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/cncr.34557","volume":"129","author":"TM Dhawale","year":"2023","unstructured":"Dhawale TM, Johnson PC, Gaballa MR et al (2023) Perception of prognosis, quality of life, and distress in patients receiving chimeric antigen receptor T-cell therapy. Cancer 129:441\u2013449. https:\/\/doi.org\/10.1002\/cncr.34557","journal-title":"Cancer"},{"key":"9925_CR12","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/PTS.0000000000001214","volume":"20","author":"M Cioce","year":"2024","unstructured":"Cioce M, Grassi S, Borrelli I et al (2024) Predictive power of dependence and clinical-social fragility index and risk of fall in hospitalized adult patients: a case-control study. J Patient Saf 20:240\u2013246. https:\/\/doi.org\/10.1097\/PTS.0000000000001214","journal-title":"J Patient Saf"},{"key":"9925_CR13","doi-asserted-by":"publisher","first-page":"235","DOI":"10.7429\/pi.2014.674235","volume":"67","author":"V Simonetti","year":"2014","unstructured":"Simonetti V, Comparcini D, Buccolini M, Cicolini G (2014) Index of caring complexity as a management tool in a surgical setting: an observational study. Prof Inferm 67:235\u2013242. https:\/\/doi.org\/10.7429\/pi.2014.674235","journal-title":"Prof Inferm"},{"key":"9925_CR14","first-page":"61","volume":"14","author":"FI Mahoney","year":"1965","unstructured":"Mahoney FI, Barthel DW (1965) Functional evaluation: the barthel index. Md State Med J 14:61\u201365","journal-title":"Md State Med J"},{"key":"9925_CR15","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1002\/nop2.792","volume":"8","author":"C Huang","year":"2021","unstructured":"Huang C, Ma Y, Wang C et al (2021) Predictive validity of the braden scale for pressure injury risk assessment in adults: a systematic review and meta-analysis. Nurs Open 8:2194\u20132207. https:\/\/doi.org\/10.1002\/nop2.792","journal-title":"Nurs Open"},{"key":"9925_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0265559","volume":"17","author":"G Guan","year":"2022","unstructured":"Guan G, Lee CMY, Begg S et al (2022) The use of early warning system scores in prehospital and emergency department settings to predict clinical deterioration: a systematic review and meta-analysis. PLoS ONE 17:e0265559. https:\/\/doi.org\/10.1371\/journal.pone.0265559","journal-title":"PLoS ONE"},{"key":"9925_CR17","first-page":"348","volume":"8","author":"D Conley","year":"1999","unstructured":"Conley D, Schultz AA, Selvin R (1999) The challenge of predicting patients at risk for falling: development of the Conley Scale. Medsurg Nurs 8:348\u2013354","journal-title":"Medsurg Nurs"},{"key":"9925_CR18","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.jpainsymman.2010.08.016","volume":"41","author":"MJ Hjermstad","year":"2011","unstructured":"Hjermstad MJ, Fayers PM, Haugen DF et al (2011) Studies comparing numerical rating scales, verbal rating scales, and visual analogue scales for assessment of pain intensity in adults: a systematic literature review. J Pain Symptom Manage 41:1073\u20131093. https:\/\/doi.org\/10.1016\/j.jpainsymman.2010.08.016","journal-title":"J Pain Symptom Manage"},{"key":"9925_CR19","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1046\/j.1365-2648.1999.01203.x","volume":"30","author":"P Mistiaen","year":"1999","unstructured":"Mistiaen P, Duijnhouwer E, Prins-Hoekstra A et al (1999) Predictive validity of the BRASS index in screening patients with post-discharge problems. J Adv Nurs 30:1050\u20131056. https:\/\/doi.org\/10.1046\/j.1365-2648.1999.01203.x","journal-title":"J Adv Nurs"},{"key":"9925_CR20","doi-asserted-by":"publisher","unstructured":"Strini V, Piazzetta N, Gallo A, Schiavolin R (2020) Barthel Index: creation and validation of two cut-offs using the BRASS Index. Acta Biomed 91:19\u201326. https:\/\/doi.org\/10.23750\/abm.v91i2-S.9226","DOI":"10.23750\/abm.v91i2-S.9226"},{"key":"9925_CR21","doi-asserted-by":"publisher","first-page":"410","DOI":"10.7416\/ai.2018.2241","volume":"30","author":"C Bravetti","year":"2018","unstructured":"Bravetti C, Cocchieri A, D\u2019Agostino F et al (2018) A nursing clinical information system for the assessment of the complexity of care. Ann Ig 30:410\u2013420. https:\/\/doi.org\/10.7416\/ai.2018.2241","journal-title":"Ann Ig"},{"key":"9925_CR22","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s00277-023-05149-x","volume":"102","author":"AM Gudmundstuen","year":"2023","unstructured":"Gudmundstuen AM, Efficace F, Tj\u00f8nnfjord GE et al (2023) The prognostic value of patient-reported outcomes in allogeneic hematopoietic stem cell transplantation: exploratory analysis of a randomized nutrition intervention trial. Ann Hematol 102:927\u2013935. https:\/\/doi.org\/10.1007\/s00277-023-05149-x","journal-title":"Ann Hematol"},{"key":"9925_CR23","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.annonc.2022.04.007","volume":"33","author":"M Di Maio","year":"2022","unstructured":"Di Maio M, Basch E, Denis F et al (2022) The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO clinical practice guideline. Ann Oncol 33:878\u2013892. https:\/\/doi.org\/10.1016\/j.annonc.2022.04.007","journal-title":"Ann Oncol"},{"key":"9925_CR24","doi-asserted-by":"publisher","first-page":"496.e1","DOI":"10.1016\/j.jtct.2021.02.029","volume":"27","author":"PC Johnson","year":"2021","unstructured":"Johnson PC, Bhatt S, Reynolds MJ et al (2021) Association between baseline patient-reported outcomes and complications of hematopoietic stem cell transplantation. Transplant Cell Ther 27:496.e1-496.e5. https:\/\/doi.org\/10.1016\/j.jtct.2021.02.029","journal-title":"Transplant Cell Ther"},{"key":"9925_CR25","doi-asserted-by":"publisher","first-page":"401.e1","DOI":"10.1016\/j.jtct.2022.05.015","volume":"28","author":"A Barata","year":"2022","unstructured":"Barata A, Hoogland AI, Kommalapati A et al (2022) Change in patients\u2019 perceived cognition following chimeric antigen receptor T-cell therapy for lymphoma. Transplant Cell Ther 28:401.e1-401.e7. https:\/\/doi.org\/10.1016\/j.jtct.2022.05.015","journal-title":"Transplant Cell Ther"},{"key":"9925_CR26","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000802","volume":"6","author":"F Efficace","year":"2022","unstructured":"Efficace F, Cannella L, Sparano F et al (2022) Chimeric antigen receptor T-cell therapy in hematologic malignancies and patient-reported outcomes: a scoping review. Hemasphere 6:e802. https:\/\/doi.org\/10.1097\/HS9.0000000000000802","journal-title":"Hemasphere"},{"key":"9925_CR27","doi-asserted-by":"publisher","first-page":"390.e1","DOI":"10.1016\/j.jtct.2021.01.003","volume":"27","author":"M Kamal","year":"2021","unstructured":"Kamal M, Joseph J, Greenbaum U et al (2021) Patient-reported outcomes for cancer patients with hematological malignancies undergoing chimeric antigen receptor T cell therapy: a systematic review. Transplant Cell Ther 27:390.e1-390.e7. https:\/\/doi.org\/10.1016\/j.jtct.2021.01.003","journal-title":"Transplant Cell Ther"},{"key":"9925_CR28","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/s41409-023-01943-3","volume":"58","author":"JR Passweg","year":"2023","unstructured":"Passweg JR, Baldomero H, Ciceri F et al (2023) Hematopoietic cell transplantation and cellular therapies in Europe 2021. The second year of the SARS-CoV-2 pandemic. A report from the EBMT activity survey. Bone Marrow Transplant 58:647\u2013658. https:\/\/doi.org\/10.1038\/s41409-023-01943-3","journal-title":"Bone Marrow Transplant"},{"key":"9925_CR29","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.jtct.2023.03.012","volume":"29","author":"KR Reyes","year":"2023","unstructured":"Reyes KR, Huang C-Y, Lo M et al (2023) Safety and efficacy of BCMA CAR-T cell therapy in older patients with multiple myeloma. Transplant Cell Ther 29:350\u2013355. https:\/\/doi.org\/10.1016\/j.jtct.2023.03.012","journal-title":"Transplant Cell Ther"},{"key":"9925_CR30","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41577-021-00547-6","volume":"22","author":"EC Morris","year":"2022","unstructured":"Morris EC, Neelapu SS, Giavridis T, Sadelain M (2022) Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy. Nat Rev Immunol 22:85\u201396. https:\/\/doi.org\/10.1038\/s41577-021-00547-6","journal-title":"Nat Rev Immunol"},{"key":"9925_CR31","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s44228-022-00004-8","volume":"4","author":"R Ellard","year":"2022","unstructured":"Ellard R, Kenyon M, Hutt D et al (2022) The EBMT immune effector cell nursing guidelines on CAR-T therapy: a framework for patient care and managing common toxicities. Clin Hematol Int 4:75\u201388. https:\/\/doi.org\/10.1007\/s44228-022-00004-8","journal-title":"Clin Hematol Int"},{"key":"9925_CR32","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.bbmt.2018.12.758","volume":"25","author":"DW Lee","year":"2019","unstructured":"Lee DW, Santomasso BD, Locke FL et al (2019) ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells. Biol Blood Marrow Transplant 25:625\u2013638. https:\/\/doi.org\/10.1016\/j.bbmt.2018.12.758","journal-title":"Biol Blood Marrow Transplant"},{"key":"9925_CR33","doi-asserted-by":"publisher","unstructured":"Anthony D, Papanikolaou P, Parboteeah S, Saleh M (2010) Do risk assessment scales for pressure ulcers work? J Wound Care 19:191\u2013196. https:\/\/doi.org\/10.12968\/jowc.2010.19.5.47849","DOI":"10.12968\/jowc.2010.19.5.47849"},{"key":"9925_CR34","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1007\/s11912-022-01272-6","volume":"24","author":"G Shouse","year":"2022","unstructured":"Shouse G, Danilov AV, Artz A (2022) Car T-cell therapy in the older person: indications and risks. Curr Oncol Rep 24:1189\u20131199. https:\/\/doi.org\/10.1007\/s11912-022-01272-6","journal-title":"Curr Oncol Rep"},{"key":"9925_CR35","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1702\/4023.39985","volume":"42","author":"S Errichiello","year":"2023","unstructured":"Errichiello S, Di Lorenzo S, Visintini C et al (2023) Haemopoietic stem cells transplantation: a narrative review. Assist Inferm Ric 42:36\u201350. https:\/\/doi.org\/10.1702\/4023.39985","journal-title":"Assist Inferm Ric"},{"key":"9925_CR36","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/s41409-023-01924-6","volume":"58","author":"R Saccardi","year":"2023","unstructured":"Saccardi R, Putter H, Eikema D-J et al (2023) Benchmarking of survival outcomes following haematopoietic stem cell transplantation (HSCT): an update of the ongoing project of the European Society for Blood and Marrow Transplantation (EBMT) and Joint Accreditation Committee of ISCT and EBMT (JACIE). Bone Marrow Transplant 58:659\u2013666. https:\/\/doi.org\/10.1038\/s41409-023-01924-6","journal-title":"Bone Marrow Transplant"},{"key":"9925_CR37","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.jtct.2022.03.006","volume":"28","author":"SJ Grant","year":"2022","unstructured":"Grant SJ, Grimshaw AA, Silberstein J et al (2022) Clinical presentation, risk factors, and outcomes of immune effector cell-associated neurotoxicity syndrome following chimeric antigen receptor T cell therapy: a systematic review. Transplant Cell Ther 28:294\u2013302. https:\/\/doi.org\/10.1016\/j.jtct.2022.03.006","journal-title":"Transplant Cell Ther"},{"key":"9925_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.879608","volume":"13","author":"RC Sterner","year":"2022","unstructured":"Sterner RC, Sterner RM (2022) Immune effector cell associated neurotoxicity syndrome in chimeric antigen receptor-T cell therapy. Front Immunol 13:879608. https:\/\/doi.org\/10.3389\/fimmu.2022.879608","journal-title":"Front Immunol"},{"key":"9925_CR39","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1001\/jama.2024.19462","volume":"332","author":"JN Brudno","year":"2024","unstructured":"Brudno JN, Maus MV, Hinrichs CS (2024) CAR T cells and T-cell therapies for cancer: a translational science review. JAMA 332:1924\u20131935. https:\/\/doi.org\/10.1001\/jama.2024.19462","journal-title":"JAMA"},{"key":"9925_CR40","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1702\/3974.39540","volume":"41","author":"S Di Lorenzo","year":"2022","unstructured":"Di Lorenzo S, Errichiello S, Cerne D et al (2022) Indications for CAR-T cell therapy and management of the complications: an update. Assist Inferm Ric 41:195\u2013211. https:\/\/doi.org\/10.1702\/3974.39540","journal-title":"Assist Inferm Ric"},{"key":"9925_CR41","doi-asserted-by":"publisher","first-page":"6283","DOI":"10.1182\/bloodadvances.2020003418","volume":"4","author":"O Penack","year":"2020","unstructured":"Penack O, Peczynski C, Mohty M et al (2020) How much has allogeneic stem cell transplant-related mortality improved since the 1980s? A retrospective analysis from the EBMT. Blood Adv 4:6283\u20136290. https:\/\/doi.org\/10.1182\/bloodadvances.2020003418","journal-title":"Blood Adv"},{"key":"9925_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102393","volume":"67","author":"O Penack","year":"2024","unstructured":"Penack O, Tridello G, Salmenniemi U et al (2024) Influence of invasive aspergillosis during acute leukaemia treatment on survival after allogeneic stem cell transplantation: a prospective study of the EBMT infectious diseases working party. EClinMed 67:102393. https:\/\/doi.org\/10.1016\/j.eclinm.2023.102393","journal-title":"EClinMed"},{"key":"9925_CR43","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.54745","volume":"8","author":"M Colacci","year":"2025","unstructured":"Colacci M, Loffler A, Roberts SB et al (2025) Patient complexity, social factors, and hospitalization outcomes at academic and community hospitals. JAMA Netw Open 8:e2454745. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.54745","journal-title":"JAMA Netw Open"},{"key":"9925_CR44","doi-asserted-by":"publisher","first-page":"e227","DOI":"10.1016\/j.clml.2024.02.006","volume":"24","author":"H Mian","year":"2024","unstructured":"Mian H, Seow H, Pond GR et al (2024) Treatment pattern, healthcare resource utilization and symptom burden among patients with triple class exposed multiple myeloma: a population-based cohort study. Clin Lymphoma Myeloma Leuk 24:e227\u2013e234. https:\/\/doi.org\/10.1016\/j.clml.2024.02.006","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"9925_CR45","unstructured":"Joint Accreditation Committee of ISCT and EBMT (2023) JACIE Standards, 8th Edition. European Society for Blood and Marrow Transplantation. https:\/\/www.ebmt.org\/sites\/default\/files\/2023-03\/JACIE%208th%20Edition%20Standards.pdf"},{"key":"9925_CR46","unstructured":"Joint Commission International (2021) Accreditation standards for hospitals, 7th edition. Joint Commission Resources. https:\/\/www.jointcommissioninternational.org\/"},{"key":"9925_CR47","unstructured":"Werley HH, Lang NM (1988) Identification of the nursing minimum data set. Churchill Livingstone"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09925-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-025-09925-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09925-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T03:40:19Z","timestamp":1760672419000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-025-09925-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":47,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["9925"],"URL":"https:\/\/doi.org\/10.1007\/s00520-025-09925-5","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"14 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The local ethics committee (Comitato Etico Territoriale Lazio Area 3) approved this study (prot. 12720\/22 ID: 4859).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"881"}}